[Percutaneous self-expanding metallic endoprosthesis and malignant biliary stenoses].
METHODS
Thirty-five patients with malignant obstructive jaundice were given palliative treatment by percutaneous self-expandable metallic stents. Cholangiocarcinoma was the most frequent cause of biliary obstruction. The stricture was located in the hilum in more of 50% of cases.


RESULTS
Adequate biliary drainage was achieved in 97% of cases. Median survival was 182 days. 11% of patients have died within 30 days. Early complications occurred in 31% of patients. 25% of patients have shown recurrent jaundice after an average of 180 days.


CONCLUSIONS
Percutaneous self-expandable metallic stents are an efficient means treating malignant biliary strictures, particularly of upper biliary obstructions.
d'Alincourt
A
A
Hôpital G, Nantes.
Lerat
F
F
Gibaud
H
H
Paineau
J
J
Leborgne
J
J
Visset
J
J
D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D000368:Aged; D000369:Aged, 80 and over; D001650:Bile Duct Neoplasms / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D017734:Bile Ducts, Extrahepatic / Q000000981:diagnostic imaging; D001653:Bile Ducts, Intrahepatic / Q000000981:diagnostic imaging; D018281:Cholangiocarcinoma / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D002758:Cholangiography; D001651:Cholestasis, Extrahepatic / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D002780:Cholestasis, Intrahepatic / Q000000981:diagnostic imaging / Q000401:mortality / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D015607:Stents; D015996:Survival Rate; D016896:Treatment Outcome
Endoprothèses métalliques auto-expansibles percutanées et sténoses biliaires malignes.